Vincent, Jean-LouisPrivalle, ChristopherSinger, MervynLorente Balanza, José ÁngelBoehm, ErwinMeier-Hellmann, AndreasDarius, HaraldFerrer, RicardSirvent, Josep MariaMarx, GernotDeAngelo, Joseph2015-07-182015-07-182015Vincent, J. L., Privalle, C. T., Singer, M., Lorente, J. A., Boehm, E., Meier-Hellmann, A., ... & DeAngelo, J. (2015). Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX)*. Critical Care Medicine, 43(1), 57-64.0090349315300293http://hdl.handle.net/11268/4216The objective of this study is to compare the effectiveness and safety of the hemoglobin-based nitric oxide scavenger, pyridoxalated hemoglobin polyoxyethylene, against placebo in patients with vasopressor-dependent distributive shock.spaVasodepresoresHemoglobinajournal article10.1097/CCM.0000000000000554restricted accessSistema cardiovascularEnfermedad cardiovascular